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INTRODUCTION 
 
   
SALIVARY gland leso 
Salivary gland lesions are among an interesting array of pathologies to the surgeon 
ranging from congenital lesions to neoplasms. These lesions comprise only about 
1.5–3% of the surgical admissions but do have an interesting role for the surgeon to 
play to ensure the recovery of these patients off their symptoms. This craftful field 
of surgery is explored in this study and the relevant medical literature is being 
presented here. 
 
 History of the Procedures: The anatomy of the parotid gland and the role of the 
main ducts were described in the mid-17th century. The earliest references to 
"para-auricular swellings," as the Greeks called them, described the findings 
associated with calculi and inflammation.  
  
From 1650-1750, salivary gland surgery was limited to the treatment of ranulas and 
oral calculi. The concept of surgical excision of a parotid tumor has been attributed 
to Bertrandi in 1802. The initial applications of this surgery included an extensive 
approach, causing serious disfiguration and disability.  
By approximately 1850, the focus shifted toward dissection and the intimate 
relationship between the facial nerve and the parotid gland. Attempts were made to 
perform the surgery with nerve preservation. John C. Warren, MD, was the first 
to use ether inhalation anesthesia during his resection of a parotid tumor in Boston 
in 1846. In 1892, Codreanu (a Romanian native) performed the first total 
parotidectomy with facial nerve preservation. Grafting of the facial nerve after 
resection was attempted in the early 1950s.  
Beahrs and Adson (1958) eloquently described the relevant anatomy and surgical 
technique of current parotid gland surgery. They stressed surgical landmarks for 
avoiding injury to the facial nerve and advocated complete removal of the 
superficial portion of  the parotid gland for noninvasive lesions confined to that 
portion of the gland. 
 
 
 
 
 
  
Review of literature 
 
The salivary gland system consists of a network of major and minor secretory 
glands and ducts, the function of which is to keep the oral cavity moist and 
lubricated and dissolve water soluble compounds as well as begin the digestion of 
starches. 
 
The salivary system consists of three pairs of major salivary glands- parotid, 
submandibular and sublingual and hundreds of minor salivary glands present 
beneath the mucosa of the upper aerodigestive tract starting from the nasal cavity, 
paranasal sinuses, nasopharynx, oral cavity, oropharynx, hypopharynx and larynx. 
Embryologically, the salivary glands are tubuloacinar glands arising from the 
ectodermal and endodermal invaginations. Histologically, major and minor salivary 
glands consist of two basic cell types- serous and mucous. The serous cells are 
polyhedral and form globular acini located at the end of microscopic ducts. Serous 
secretions from these acini empty into smaller duct systems which lead to 
branching larger duct systems and eventually into the main excretory duct. Mucous 
cells are cuboidal cells and also form acini. Approximately 1500ml of mucoserous 
fluid is produced per day, of which 90% is from parotid and submandibular, 5% 
from sublingual and remainder from minor salivary glands. 
 
  
The pathologies affecting these glands can be broadly classified into neoplasms and 
non-neoplastic lesions which are further sub classified into inflammatory, 
autoimmune, infectious, traumatic , congenital and other rare lesions. The role of 
surgical cure in salivary glands is well known and proven beyond doubt in cases of 
neoplasms and inflammatory swellings, which forms the principal concern of this 
study. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Surgical Anatomy 
 
Parotid gland: 
 
  The parotid gland is the largest of the salivary glands which lies 
between the zygomatic arch and the angle of the mandible. the parotid 
compartment is a space that contains the parotid gland, facial nerve and its 
branches, sensory and autonomic nerves, external carotid artery and its branches, 
posterior facial vein and lymphatics. About 80%   of the gland lies on the outer 
surface of the masseter muscle and  the ramus and the angle of the mandible and 
the remaining 20% of the gland extends medially through the stylomandibular 
tunnel formed ventrally by the posterior edge of the mandibular ramus, dorsally by 
the anterior borders of sternocleidomastoid muscle and the posterior belly of the 
digastric muscle and more deeply and dorsally by the stylomandibular ligament, 
and this ligament separates parotid from the submandibular gland. The retro 
mandibular portion of the parotid lies in the prestyloid compartment of the para-
pharyngeal space, being anterior to the styloid process and its musculature, the 
carotid sheath and the cranial nerves IX, X, XI,XII. Hence a parotid tumour may 
appear intra orally pushing the soft palate and tonsillar fossa anteromedially. The 
constricted area of the gland between the ramus of the mandible and posterior belly 
of digastric connecting the superficial and deep portions is called the “isthmus”. 
The average dimension of the gland in the cranio-caudal direction is 5.8cm and in 
  
the dorso-ventral direction is 3.4 cm. The gland tends to be slightly smaller in 
women. 
  Although not found in all 
glands, five processes of the parotid gland have been described. Three of them are 
superficial, which are the condylar, meatal and posterior processes. And the deep 
processes are glenoid and stylomandibular. Because of the multiple processes and 
the limitations imposed by an intact facial nerve, it is nearly impossible to remove 
all parotid tissue even when a total parotidectomy is attempted. The parotid duct 
emanates from the anterior aspect of the superficial component of the gland, 
courses anteriorly on the lateral surface of the masseter muscle and buccal fat pad, 
and then turns medially almost at right angle, piercing the buccinator at the level of 
the second maxillary  molar tooth. The general course of the parotid duct is in the 
  
direction paralleling the zygomatic arch, traversing approximately 1 cm inferior to 
the arch. Stensen’s duct passes over the masseter, may receive the duct of an 
accessory parotid gland, found in about 20% overlying the masseter muscle, 
usually cranial to the Stensen’s duct. 
 
NEUROVASCULAR ANATOMY: 
 
  The greater auricular, auriculo temporal and facial nerves traverse the 
most superficial portion of the parotid gland(mylohyoid neural compartment). 
From the inception of the surgery, usually the first neural structure encountered is 
the greater auricular nerve when the skin flaps are raised. This nerve divides into 
anterior and posterior branches. Preservation of the posterior division of the nerve 
is possible during removal of smaller parotid tumours and those located away from 
the tail of the parotid gland. 
 
  The  auriculo temporal nerve , a branch of the V cranial nerve, is 
found in the posterior aspect of the gland, coursing superiorly with the superficial 
temporal artery and vein. It is a sensory nerve to the temporal region and carries 
parasympathetic fibres to the parotid gland from the otic ganglion. 
  
 
 
  The facial nerve exits the stylomastoid foramen from its intra temporal 
course. After the nerve exits the stylomastoid foramen, it gives off immediate 
branches to the stylohyoid, posterior belly of digastric, and postauricular muscles 
before its transition to the pes anserinus. The facial nerve enters the parotid gland 
on its posterior surface prior to the formation of the pes anserinus, about 1.3 cm 
from the stylomastoid formaen. From the pes, two major portions of the facial 
nerve are formed-the cervicofacial and temporofacial divisions. The cervico facial 
division gives rise to marginal mandibular and 
  
 cervical 
branches, and the temporofacial division gives rise to the temporal, zygomatic and 
buccal branches. There are six types of branching patterns being described for the 
facial nerve, none of them being the predominant one. The surgeon should keep in 
mind that the there is a tendency for cross-innervation between the buccal and 
zygomatic branches. During parotidectomy, each branch of the nerve is traced and 
the parotid tissue lateral to the branches(in superficial parotidectomy) and both 
lateral and medial to the branches(in total parotidectomy) is removed. 
 
  The veins traverse the middle portion of the gland deep to facial nerve. 
The superficial temporal vein unites with the internal maxillary vein to form the 
posterior facial vein, which branches into anterior and posterior divisions. The 
anterior branch joins the anterior facial vein to form the common facial vein, 
  
whereas the posterior division unites with the posterior auricular vein to form the 
external jugular vein. On its descent, the external jugular vein is found on the 
lateral aspect of the sternocleidomastoid muscle , anterior to the greater auricular 
nerve. This anatomic arrangement is often used to help locate the proximal portion 
of the nerve for grafting purposes. 
 
  The external carotid artery and its terminal branches, the internal 
maxillary and the superficial temporal arteries, traverse the deep portion of the 
parotid gland(arterial compartment). The superficial temporal artery ascends 
between the mandibular condyle and external auditory canal. Precise localization of 
this artery occurs just at the root of the zygoma anterior to the auricle. The internal 
maxillary artery, which may be encountered during total parotidectomy or removal 
of deep lobe tumours in the para-pharyngeal space, is found between the 
mandibular ramus and sphenomandibular ligament, coursing in close proximity to 
the lateral pterygoid muscle and heading toward the pterygopalatine fossa. 
 
  Superficial temporal vessels provide blood supply to the temporo-
parietal fascial flap, which can be used for recontouring defects in the parotid bed. 
Internal maxillary vessels and the deep temporal branches should be preserved 
whenever possible, as they provide blood supply to the temporalis muscle which is 
often used for dynamic rehabilitation of facial paralysis. 
 
  
  The parotid gland is associated with a rich network of lymphatics. 
During embryogenesis, the parotid anlagen is first to develop but it becomes 
encapsulated after the submandibular and sublingual glands. The lymphatic system 
develops from the mesoderm prior to parotid gland encapsulation, and after the 
submandibular and sublingual glands encapsulate. This delayed encapsulation of 
the parotid gland is critical because it results in the entrapment of the lymph nodes 
and lymphatic channels within the glandular parenchyma. In addition, during 
encapsulation of the intraparotid and periparotid lymphnodes, salivary epithelial 
cells can be included within these nodes. It is this special embryogenesis of the 
parotid gland that is believed to play a roe in the development of warthin’s 
tumours, and possibly lymphoepithelial cysts. The pre auricular and infra-auricular 
lymph nodes constitute the para-parotid group, which drain the temporal region, of 
the scalp and auricle. The intraparotid nodes receive lymphatics from the posterior 
nasopharynx, soft palate and ear. Hyperplastic changes or neoplastic involvement 
of these nodes may manifest as parotid mass. 
Parotidomassteric fascia 
 
  The superficial or anterior layer of the deep cervical fascia extends 
from its attachment on the hyoid bone upward to the mandible, and from the 
anterior border of the sternocleidomastoid upward to the mandible and zygomatic 
arch. 
  
  More posteriorly, at the level of the submandibular gland, the 
superficial layer splits to form a capsule about this gland, still more posteriorly 
about the insertions of the masseter and medial pterygoid muscles, it splits to 
enclose these muscles and the intervening angle and ramus of the mandible, one 
portion of the masseteric fascia, following the external surface of the masseter to 
the zygomatic arch and the other portion following the internal surface of the 
medial pterygoid to the pterygoid plate. 
 
  Finally, behind the angle of the jaw and anterior to the 
sternocleidomastoid, this layer of fascia passes upward towards the zygomatic arch 
as the parotid fascia. Grodinsky and Holyoke described it as splitting to form a 
capsule about the parotid gland before attaching to the zygomatic arch. The 
potential spaces formed by the splitting of the superficial layer of fascia are all 
closed spaces. 
 
  As in the case of the submandibular gland, the parotid gland is 
attached to its surrounding fascia, and the parotid “space” is therefore not so much 
anatomical as a clinical one. The density, lack of elasticity and the 
compartmentalization of the fascia prevent stretching of the capsule to 
accommodate a suppurative or other rapidly expanding intraparotid process. The 
deep portion of the parotid fascia that contributes to the stylomandibular ligament 
and passes downward to fuse with the fascia of the posterior belly of the digastric 
  
and the angle of the mandible serves to separate the parotid gland from the 
submandibular gland. 
 
Lymphatic drainage 
 
  Parotid gland contains two groups of lymphnodes: 
 
  1.Superficial group: they are situated under the superficial 
parotid fascia. The pre-auricular node belongs to this group. They drain lacrimal 
gland, eyelid, cheeks, root of nose, external auditory canal, scalp and pinna. 
 
  2.Deep group:  they are situated in the substance of the 
gland. Apart from parotid gland, lymphatics from external auditory canal, middle 
ear, soft palate and post-nasal cavities drain into these groups of nodes. 
 
  Both superficial and deep groups drain into the upper deep cervical 
nodes. 
 
The submandibular gland 
   
  The submandibular gland possesses a superficial and deep 
component(lobes), which wrap around the posterior border of mylohyoid muscle. It 
  
is ensheathed by the superficial layer of the deep cervical fascia, like the parotid 
gland. The main excretory duct of the gland(Wharton’s duct) emanates from the 
deep component  of the gland and courses between the hyoglossus/genioglossus 
muscles and the inner surface of the mandible, coursing toward the floor of the 
mouth, it ends as a papilla adjacent to the lingual frenulum in the floor of the 
mouth. The duct at first lies medial to the lingual nerve, but then as the lingual 
nerve loops down, the duct assumes a position  lateral to the lingual nerve. The 
distal hypoglossal nerve is situated between the submandibular gland and the 
hyoglossus muscle above the hyoid bone. It is located deep to the posterior belly of 
the digastric muscle  and stylohyoid muscle prior to entering the submandibular 
triangle. Identification of the submandibular duct, lingual nerve, and hypoglossal 
nerves is mandatory prior to the removal of the submandibular gland. 
 
  The marginal mandibular branch of the  VII nerve courses directly 
over the submandibular gland in the plane over the gland and beneath the platysma 
muscle layer in a significant percentage of people. It may be encountered during 
transcervical approach to the gland and should be identified meticulously and 
preserved. Injury to this single nerve will cause a large and noticeable degree of 
facial asymmetry. 
 
  Facial artery courses deep to the posterior belly of digastric and 
stylohyoid muscles and under the submandibular gland, then traverses between the 
  
submandibular gland and mandible to ascend toward the face. The facial vein 
courses in the general direction of the facial artery , but the major distinction is that 
the facial vein runs on the lateral surface of the gland. The facial vein also runs 
under the marginal mandibular nerve. In fact one maneuver to preserve the 
marginal mandibular nerve is to ligate the facial vein 2 to 3 cm below the mandible 
and lift the tissues above the ligated vein and then the nerve will be lifted 
superiorly with the vein. 
 
Lymphatic drainage  is to the submandibular nodes and then to the jugular chain. 
 
The sublingual and minor salivary glands 
 
  The sublingual gland is located undercover of the mandible. It is 
covered by the thin mucosa of the floor of the mouth, resting on the genioglossus 
muscle. The gland possesses 8 to 20 smaller ducts (duct of Rivinus) which empty 
into the floor of the mouth. Occasionally, the anteriorly located ducts may join to 
empty into a larger duct (Bartholin’s duct) adjacent or into the sublingual caruncle 
along with the submandibular duct. 
 
  The minor salivary glands number in the range of 600 to 1000 and 
spread throughout the upper aerodigestive tract. Areas of concentration include the 
posterior palatal, buccal, labial and lingual regions. 
  
 
The para-pharyngeal space 
 
  Understanding the anatomy of the Para pharyngeal space is crucial for 
removal of deep lobe parotid tumours. If  one could imagine the Para pharyngeal 
space taking on the shape of an inverted pyramid, the base of the pyramid will be 
resting along the skull base and the apex directed inferiorly at the greater cornu of 
the hyoid bone. The medial border of the Para pharyngeal space is the muscular 
pharyngeal wall, and the lateral border is the medial pterygoid muscle and 
mandibular ramus. The normal contents of the space include fat, the internal 
maxillary artery, ascending pharyngeal artery and pharyngeal venous plexus. Deep 
lobe parotid tumours will extend into the space by growing between the 
stylomandibular ligament and bony mandible, taking the pathway of least 
resistance. 
 
  The Para pharyngeal space is divided into pre and post styloid 
compartments by an imaginary line, which is appreciated best on CT scan, from the 
styloid process to the medial pterygoid plate. Pre operative determination of the 
growth characteristics and extension of the tumour within the Para pharyngeal 
space by axial imaging may provide pre operative clues to the pathology of  the 
tumour. 
 
  
Histiogenesis of salivary gland neoplasms 
 
The mature salivary  gland unit is made up of serous or mucous acini that lead to an 
intercalated duct, which in turn is connected to a striated duct that finally empties 
into an extra lobular excretory duct. Myo epithelial cells are located around the 
periphery of the acini and the intercalated duct. 
Theories of  tumour histiogenesis: 
 
1.Multi cellular theory: 
 
 The  genesis of neoplasms from their adult differentiated counterparts of the 
salivary gland unit e.g.. acinic cell carcinomas would originate from acinar cells, 
oncocytic tumours from striated duct cells, squamous cell carcinomas and 
mucoepidermoid carcinomas from excretory duct cells, and all other adenomas and 
adenocarcinomas from intercalated duct cells. 
 
2.Bi cellular theory: 
 Neoplasms generate from the two undifferentiated reserve cells called 
excretory duct reserve cell and the intercalated duct reserve cell. This theory is 
more plausible because it does not require dedifferentiation of already highly 
specialized cells such as acinar and striated duct cells. 
  
Some of the factors which are considered as risk factors for the development of 
salivary gland neoplasms are 1. low dose radiation – both benign and malignant 
neoplasms 
   2. smoking – associated with the development of warthin’s 
tumour 
   3. chromosomal anomalies – allelic loss on chromosome 12q in 
pleomorphic adenoma, translocation breakpoint at 12q & 15 in pleomorphic 
adenoma, 8q & 12 translocation involving PLAG 1 (a zinc finger protein) 
   4. exposure to silica dust and parotid cancer 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
Differential diagnoses of salivary gland swellings include: 
 
1. Non-neoplastic disorders 
Infectious  
• Acute sialadenitis 
• Chronic recurrent sialadenitis 
• Viral parotitis 
i. Paramyxovirus 
ii. CMV 
iii. Coxsackie virus 
• Granulomatous parotitis 
i. Tuberculosis 
ii. Cat scratch disease 
• Actinomycosis 
Non-infectious 
• Sialectasis 
• Sialolithiasis 
• Sjogren’s syndrome 
• Sarcoidosis(uveoparotid fever of Heerfordt) 
• Benign lymphoepithelial lesion 
  
• Radiation sialadenitis 
• Ptyalism 
• Sialadenosis 
i. Vitamin deficiency 
ii. Malnutrition 
iii. Bulimia 
iv. Diabetes 
v. Hypothyroidism 
vi. Alcoholic cirrhosis 
vii. Drugs – thiourea, clonidine, alpha-methyl dopa 
viii. Hemangioma 
ix. Cysts  
x. Chronic sclerosing sialadenitis of submandibular 
gland(Kuttner tumour) 
xi. Necrotizing sialometaplasia 
2. Neoplastic disorders 
Benign  
• Pleomorphic adenoma 
• Monomorphic adenoma 
i. Basal cell adenoma 
ii. Glycogen – rich adenoma 
iii. Clear cell adenoma 
  
iv. others 
• Warthin’s tumour 
• Oncocytoma  
• Sebaceous adenoma 
• Sebaceous lymphadenoma 
• Papillary ductal adenoma 
• Hemangioma  
 
Malignant 
• Mucoepidermoid carcinoma 
• Acinic cell carcinoma 
• Adenocarcinoma 
• Adenoid cystic carcinoma 
• Malignant mixed tumour 
• Squamous cell carcinoma 
• Malignant oncocytoma 
• Lymphoma 
• Metastases 
i. Melanoma 
ii. Squamous cell carcinoma 
iii. Metastases to intra parotid lymphnodes 
  
History, physical examination and investigations 
 
Patients with salivary gland disorders usually present with asymptomatic, slowly 
enlarging masses. Pain related to a salivary gland neoplasm does not confer a 
higher risk of malignancy and pain is a consistent feature of inflammatory lesions, 
related to meals in cases of obstruction to the salivary flow especially in 
sialolithiasis. Associated infection, hemorrhage in cases of tumours may produce 
pain. The neoplastic lesions are commoner in the tail of the parotid and 
submandibular gland neoplasms present as enlargement of the gland itself, whereas 
minor salivary gland neoplasms present as submucosal painless masses on the 
palate or in the floor of the mouth. They may rarely masquerade as paranasal sinus 
neoplasms causing obstructive symptoms of sinusitis, nasal obstruction,epistaxis 
and others. Para pharyngeal space neoplasms are often diagnosed late in their 
evolution because of the lack of presenting symptoms until a large size has been 
attained. Dysphagia or muffled ‘hot potato’ voice may be the first indication of the 
presence of  tumour in the Para pharyngeal space. A thorough general medical 
history is elicited to provide clues to systemic inflammatory or infectious etiologies 
of salivary gland enlargement that may be mistaken for a neoplastic process. 
 
 Physical examination of salivary gland masses assumes that a thorough 
general head and neck examination is performed. Facial nerve function is noted 
carefully and documented. Rapid growth, fixation to adjacent structures, associated 
  
cervical adenopathy, ulceration and facial or other nerve involvement suggest 
underlying malignancy.  
 
 Fine needle aspiration cytology is a simple and reliable method for obtaining 
diagnosis of a salivary gland neoplasm. Eneroth et al first reported FNAC of a 
salivary gland tumour..(1967). The sensitivity and specificity of FNAC for salivary 
gland tumours reported in literature range from a high of 99% sensitivity and 100% 
specificity ( Bhatia et al..) to a low of 90%sensitivity and 75% specificity(Cohen et 
al..) in general, however, recent series document a trend toward a higher degree of 
sensitivity and specificity. A higher degree of accuracy has been reported for 
benign tumours. Mucoepidermoid carcinomas appear to be the most difficult to 
diagnose by FNAC. To improve the diagnostic accuracy of FNAC, special 
immunohistochemical stains such as glial fibrillary acidic protein for pleomorphic 
adenomas and silver staining of nucleolar organizer regions have been used. this 
investigation is essentially free of complications, though there are reports of 
hemorrhage and necrosis of the tumour following aspiration in case of Warthin’s 
tumour and lymphoma, the occurrence of which is extremely rare. And many 
specific reports have alleviated the concerns over needle track seeding. 
 CT scan is an excellent imaging modality for salivary gland lesions and is of 
value for a guided FNAC in case of deep lobe lesions or relatively inaccessible 
lesions. A CT scan can better define the extent of nodal metastases and infiltration 
into vital neurovascular structures in malignant lesions, and CT is more valuable 
  
than MRI in case of inflammatory disorders. MRI , Tc99m scan, Gallium scan, 
USG and sialography are other modalities which may be of immense help in 
certain difficult cases but not routinely mandatory given the cost-benefit ratio. And 
the role of open biopsy in cases of salivary gland lesions is controversial and very 
minimal, as for example in cases of doubtful malignancy and a lesion which is 
discordant between clinical and cytological features. 
 
Clinical features: 
The various disorders that affect salivary glands and their clinical and pathological 
features are beyond the scope of this literature review and only salient features of 
relevant pathological diagnoses are to be illustrated in brief. 
 
Non-neoplastic lesions: 
 
 Sialadenosis: The salivary  gland can enlarge for nutritional reasons not 
related to neoplastic cellular changes, which is found in association with cirrhosis 
and malnutrition. 
 
 Sialadenitis: The gland can become enlarged from inflammatory conditions. 
These can be due to trauma to the maxillofacial area, viruses, or bacteria 
(Staphylococcus aureus most commonly), which can lead to abscess formation. 
  
Unusual causes of enlargement have been found to be related to sarcoidosis, in 
which case multiple salivary glands may be found to be enlarged. 
 
 Sialolithiasis: Stones in the ducts of the salivary glands are a common 
condition leading to a mass within the gland or enlargement of the gland secondary 
to obstruction of salivary flow. Most of these are found in the submandibular gland 
and a lesser number in the parotid gland. A sialogram may sometimes show no 
stones but rather a stenosis from previous trauma that leads to obstructed or 
restricted flow. 
 
 Mucocele:  These retention cysts of mucus production are most commonly 
found in the minor salivary glands. These are frequently located in the lower lip, 
and they sometimes develop after trauma to the lip, laceration and suture repair, or 
secondary healing. 
 
 Necrotizing sialometaplasia: This is an unusual and clinically disturbing 
lesion that has an uncertain cause. It may or may not be related to trauma to the 
oral mucosa but is manifest as an enlarging and often painless ulceration. It is more 
commonly found in the palatal mucosa but can also be seen in the buccal mucosa 
or the lips. It is a self-limited process and heals on its own, or it may be diagnosed 
by histologic examination after it is removed for not healing. 
 
  
Benign neoplastic lesions: 
 
Pleomorphic adenoma:  Also known as the benign mixed tumour, this is 
the most common tumour of the salivary glands. The tumour was originally 
believed to be “mixed” neoplastic cells derived from both duct epithelial cells and 
myoepithelial cells. However, it is now known to be a neoplasm of purely 
ectodermal cells. 
 These tumours most commonly occur in the parotid glands (80 to 90%) and 
appear as painless,’ rubbery’ firm 1 to 2 cm masses in the deeper tissue. They are 
not attached to the overlying skin, and they do not cause any muscle dysfunction by 
pressure on the motor branches of the facial nerve. They can rarely be found 
bilaterally. 
 On histological examination, there is a distribution of mostly epithelial and 
stromal(mesenchymal) cells. These mesenchymal areas of the tumour may consist 
  
of chondroid or hyalinized stroma that has the microscopic appearance of hyaline 
cartilage.  
 A preoperative diagnosis may be made by cytologic examination of a biopsy 
sample from FNA. The diagnosis is usually made after the tumour mass is removed 
with surrounding normal gland by means of resection of the entire segment of the 
parotid gland superficial to the plane of the facial nerve. The recurrence rate 
following this procedure is usually low in the range of 1%. On occasion, the 
  
tumour is located in the deep segment of the parotid gland, requiring dissection of 
the facial nerve to protect the nerve and subsequently to remove the deep tumour. 
 Recurrent pleomorphic adenomas are uncommon but require careful 
management. They are best controlled by aggressive surgical removal and total 
parotidectomy when necessary to achieve long-term control rates of better than 
90%. Postoperative radiation therapy has been shown to be effective in improving 
control rates in those patients at high risk for recurrence. Recurrence may also 
occasionally (less than 1%) be manifested as a transformation to malignant mixed 
tumour. 
 
Warthin’s tumour(papillary  cystadenoma lymphomatosum): The 
second commonest benign tumour of the parotid gland, accounting for 6 to 10% of 
all parotid tumours. Found almost exclusively in the parotid, commoner in men in  
their fifth decade of life, it is clinically detected as a smooth mass, 3 to 4 cm in 
diameter, in the superficial segment of the gland and is bilateral in 10% of  cases. 
 These tumours are derived from the proliferation of lymphoid tissues of 
periparotid or intraparotid lymph nodes. As such, they are believed to be 
proliferative tumours rather than neoplastic tumours. Grossly these tumours can 
have multiple cystic spaces and needle aspiration can yield a chocolate brown fluid. 
The tumour is well known for its “hot” appearance in technetium scans as it 
consistently concentrates this isotope. They are said to be associated with tobacco 
smoking and the increased incidence in females is attributed to the increasing use 
  
of the same by females. Recurrence rates following surgical removal with a rim of 
normal tissue is extremely low and if present, signifies multicentric foci. Theories 
of origin of these tumours include  1. ectopic epithelial theory, 2. atypical 
hypersensitivity reaction theory, 3. branchial remnant theory. 
 
Malignant  neoplastic lesions: 
 
 “The usual tumour of salivary gland is a tumour in which the benign variant 
is less benign than the usual benign tumour and the malignant variant is les 
malignant than the usual malignant tumour” (Acherman L.V et al..) 
 Most malignant salivary gland tumours arise from either the  excretory duct 
or the intercalated duct reserve cell. Either of these two cells have the potential for 
differentiation into a variety of epithelial tumours. 
 Mucoepidermoid carcinoma:  It is the most common malignant tumour of 
the parotid gland and the second most common malignant tumour of the 
submandibular and minor salivary glands. The first reported case of 
mucoepidermoid carcinoma was in 1895, but it received its current name in 1945, 
based on the two main cellular components noted on microscopic examination- 
mucous cells and epidermoid cells. The palate is the second most common location 
for mucoepidermoid carcinomas. All mucoepidermoid tumours currently are 
believed to be carcinomas. Based on the  relative ratios of the two cell types, they 
are divided into low, intermediate and high grades. Low-grade tumours have 
  
numerous mucous cells and cystic spaces, whereas high-grade tumours may 
resemble a squamous cell carcinoma. 75% of these tumours are low grade. 
 
 Microscopically the tumour is composed of varying percentages of six cell 
types. The maternal cell is the progenitor of the other five. The intermediate cell 
may differentiate into either glandular or epidermoid forms, and the epidermoid 
cell may resemble closely squamous cell carcinoma with individual cell 
keratinization, keratin pearls and intercellular bridges. The clear cell has a distinct 
outline with hydropic, water clear cytoplasm. The columnar cell resembles cells 
found in the major secreting ducts. The sixth cell is the mucous cell. Most low-
  
grade mucoepidermoid carcinomas present in a manner indistinguishable from 
pleomorphic adenoma.  
 
Adenoid cystic carcinoma:  The name adenoid cystic carcinoma was coined 
in 1953 by Forte and Frazell. This is the second most common malignant tumour of 
the salivary glands. The hallmark of this carcinoma is its propensity to perineural 
invasion. 
There are three histological subtypes based on appearance: cribriform, tubular and 
solid. The cribriform pattern has the classic “Swiss cheese appearance” and in this 
type, cells are separated by round or oval spaces that appear to be cysts but are not. 
They are merely extracellular spaces lined by replicated basement membrane 
material. The tubular or “trabecular” pattern has a more glandular architecture, 
where as the solid pattern shows sheets of cells with little or no luminal spaces. The 
tubular variety has the best prognosis, where as the solid has the worst. 
 
 Malignant mixed tumour:  Three different neoplasms have been included 
under the generic term malignant mixed tumour. Two are malignant from the 
beginning, the first of which is a histologically benign metastasizing pleomorphic 
adenoma. This lesion is a clinical and pathological curiosity. The second is a 
tumour with both a malignant epithelial component and a malignant myoepithelial 
component. In addition, the metastases contain both elements, and this lesion is a 
true carcinosarcoma. The third type, the carcinoma ex-pleomorphic adenoma, 
  
represents the malignant transformation of the epithelial component within a pre 
existing pleomorphic adenoma. Only the epithelial component metastasizes. The 
risk of malignant transformation of a pleomorphic adenoma increases with the 
duration of the tumour and rises from about 1.5% within the first 5 years to 9.5% 
after 15 years. The sites of origin in decreasing frequency of carcinoma-ex-
pleomorphic adenoma are the parotid, submandibular gland, palate, lip, paranasal 
sinuses, nasopharynx and tonsil. 
 
Treatment 
Benign tumours 
 
  The treatment of benign tumours of the parotid gland has passed 
through several phases during the past 30 years. Surgery is the treatment of choice 
for al salivary gland tumours. 
 
 
Parotid gland:   If it is a slow growing tumour, superficial conservative 
parotidectomy is the treatment of choice. If the tumour is present in one of the 
poles, then hemi superficial parotidectomy can be done. When the biopsy report 
turns out to be malignant then postoperative radiotherapy is advocated n a dose of 
5000-6000 cGY in fraction over 5-6 weeks. Total parotidectomy is done for deep 
lobe tumours and dumbbell tumours. 
  
 
Submandibular gland:   Excision of the gland with preservation of lingual and 
hypoglossal nerve is advised. 
 
Minor salivary gland tumours:   After confirmation of clinical diagnosis by FNAC, 
excision of the tumour with wide margin of normal tissue is the treatment of 
choice. There is no need to sacrifice the underlying bone. The raw area may 
primarily be grafted with SSG or allowed to heal by granulation. 
 
Intra operative issues:     
  From the onset, use of paralytics or muscle relaxants should be 
avoided by the anesthesiologist. This is done so that either electromyographic 
monitoring of the facial musculature or nerve localization by electrostimulation is 
permitted during the operation. The use of intraoperative facial nerve monitoring 
through the use of  nerve integrity monitors can be done. 
  Hemostasis is improved with the use of bipolar cautery in areas 
adjacent to the facial nerve to help reduce thermal injury to the nerve. Recently, the 
Shaw scalpel has been used in parotidectomy to curb excessive blood loss and 
improve visualization in the operating field. the Shaw scalpel is a thermally 
activated scalpel, popularly known as the ‘hot knife’. Bipolar scissors with saline 
irrigation for faster dissection in a relatively bloodless field, harmonic scalpel all 
serve to improve  intra-operative hemostasis  
  
Complications of surgery: 
Early: 
1.Facial N neuropraxia 2.Facial N injury 3.Hemorrhage 
4.Hematoma and seroma 5.Sialocele  6.Flap necrosis 
7.Salivary fistula  8.Infection  9,Otitis externa 
 
Late: 
1.Frey ‘ s syndrome  2.Cosmetic deformity 
 
Frey’s syndrome is the occurrence of redness and sweating on the temple in the 
area of distribution of the auriculotemporal nerve when eating, which is seen in few 
patients after parotidectomy. This is caused by regeneration of the secretory fibres 
of the parotid gland, contained in the auriculotemporal nerve, to sweat glands in its 
area of distribution. Thus the sweat glands respond to the nerve impulses that are 
meant to stimulate parotid secretion. It can be relieved by section of the IX nerve 
which carries the preganglionic fibres for the parotid gland(Gardner). 
 
Facial nerve paralysis- treatment options: 
 
• Neurorraphy 
• Interposition nerve grafts 
• Crossover reinnervation procedures 
  
i. Hypoglossal 
ii. Ansa hypoglossi 
iii. Cross facial 
• Regional muscle transfer 
i. Temporalis 
ii. Massseter 
iii. Digastric 
• Microneurovascular free flap 
i. Gracilis 
ii. Latissmus dorsi 
iii. Rectus abdominis 
iv. Serratus anterior 
v. Pectoralis major 
vi. Abductor hallucis 
vii. Extensor digitorum brevis 
Static reanimation and cosmetic procedures: 
• Eyelid procedures 
i. Gold weight 
ii. Spring 
iii. Lower lid tightening 
• Brow & forehead lift 
• Correction of midfacial deformity slings 
  
i. Fascia lata 
ii. Alloplastic sheets 
iii. Malar augmentation 
• Facelift operation 
• Lower lip wedge resection 
• Botulinum toxin 
Adjuvant therapy: 
 
 Radiotherapy:  The indications for and techniques of radiation therapy to be 
used as well as the response of salivary gland tumours to treatment depend upon 
the location of the primary lesions as well as extent and histologic make out. It is 
used as  
 Curative – as an adjuvant to surgery 
 Palliative –  in inoperable tumours 
for recurrent lesions 
  symptomatic treatment of distant metastasis 
Indications for adjuvant radiotherapy to tumour bed are as follows: 
• High grade histology(e.g.. mucoepidermoid carcinoma) 
• All cases of adenoid cystic carcinoma 
• Advanced stage of the primary 
• Positive tumour margin 
  
• Intraoperative tumour spillage 
• Facial nerve involvement 
• Positive neck nodes 
• Deep lobe of parotid involvement 
Since skip metastasis is possible, the entire neck should be irradiated. It is 
used as a dose of 6000-6500 cGy in fractionated doses over 6-7 weeks. 
The complications of radiotherapy are: 
 Ageusia  Trismus  Diminished salivation 
 Caries tooth  Mucosal necrosis Osteonecrosis  
 
Chemotherapy:  It is used as a palliative treatment for recurrent or metastatic 
salivary gland malignant neoplasms. Single drug therapy is commonly used with 
either one of the following- doxorubicin, 5-FU, methotrexate, cyclophosphamide, 
cisplatinum. Combination chemotherapy using regimens like 
CAP(cyclophosphamide, adriamycin, cis platinum) and FACP(5-
FU,adriamycin,cyclophosphamide,cis-platinum) 
 
Newer innovations: Advances in surgical techniques have enabled teams of head 
and neck surgeons and neurosurgeons to remove cancers that have spread near the 
base of the skull. These operations were not considered possible a few years ago 
but are becoming more common and successful.  
  
Reconstructive surgery is becoming more sophisticated and successful. This 
permits more extensive surgery to be done and improves patient’s’ quality of life 
after treatment.  
Advances in radiation therapy now permit more precise targeting of radiation. 
Some types of radiation, such as fast neutron beam radiation and conformal 
radiation therapy have been found to be particularly useful but require specialized 
equipment that is not available in many hospitals.  
Researchers are learning more about how certain changes in DNA cause salivary 
gland cells to become malignant. For example, they have discovered that DNA 
from 2 chromosomes may undergo translocations (switch positions). These 
changes often cause activation of genes that control cell growth. For example, 
adenoid cystic carcinomas often have translocations involving chromosomes 6 and 
9; in mucoepidemoid carcinomas, the translocations usually involve chromosomes 
11 and 19. As scientists learn more about these and other DNA changes, they hope 
to use this information to develop new treatments for salivary gland cancers that 
are more effective and cause fewer side effects.  
Because advanced salivary gland cancer is rare, knowledge about treating these 
cancers with chemotherapy is still evolving. New chemotherapy drugs and other 
anticancer drugs are expected to provide more options for people with advanced 
salivary gland cancer.  
Targeted therapy: Drugs have been developed for other cancers that attack certain 
molecules in the cancer cell. This prevents the cancer from growing. These have 
  
had some success in treating a host of other cancer types and are being tested in 
clinical trials in people with salivary gland cancer 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Aims and objectives 
 
 
The  objectives of this study on surgical outcomes in 
salivary gland swellings are 
(i)To assess the surgical outcomes of salivary gland surgeries 
(ii)To evaluate the factors that contribute to the decision-
making processes in salivary gland surgery   
(iii)To document the various clinical  presentations and the 
associated epidemiological values 
(iv)To scrutinize and propose management protocols for the 
various surgically treatable disorders – benign, malignant and 
non-neoplastic – that affect these glands 
(v)To document and deal with the complications which occur 
following surgery on these glands 
 
 
 
 
 
Materials and methods 
 
  
  This study principally confined itself to those patients with salivary 
gland swellings, who were operated in Thanjavur medical college hospital between 
July 2005 and October 2007. 
 A meticulous proforma was prepared which included a thorough history, 
elaborate account of the clinical features and details regarding pre-operative 
investigations, operative notes and post-operative complications. All biopsy reports 
were collected and analysis done incorporating all these data. The final 
histopathological report was taken as confirmative of a salivary gland lesion and 
patients were excluded if the report did not confirm to be a salivary glandular 
lesion. 
 The pre-operative investigations included Fine Needle Aspiration Cytology 
of the lesion in all cases and CT scan, ultrasonography, sialogram were done for 
select cases. Other basic investigations for assessment purposes were done as per 
the institutional policies. 
 The study included only patients who were operated in our institution- under 
all the six general surgical units, plastic surgery, paediatric surgery and 
otorhinolaryngolgy units. 
 
Observation and discussion 
 
  
 The total number of patients who had undergone surgery on salivary glands 
in the study period (July 05 to October 07) is 87. This group of patients was 
analyzed and the following inferences were obtained. This cohort of 87 proves a 
commendable number as the previous studies involving only neoplasms of the 
salivary glands in our institution give a rough incidence rate of 17 cases per year. 
 
 The distribution based on sex(values in percentages): 
 TMCH Izandro RB et al Malaita JK et al 
Male 53 43.3 61 
Female 47 56.7 39 
M:F ratio 1.12 : 1 1 : 1.3 1.5 : 1 
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                            There was no significant sexual predominance of salivary gland 
lesions which is also confirmed by certain other studies as shown in the table. 
 
Age wise analysis: 
The youngest among our patients was a 3 ½ year old child and the oldest was  70 
year old females(2 patients).The distribution shows that majority of these lesions 
occur in middle-aged individuals. The mean age in our study was 39.6 years, the 
median age being 40 years.  
 When distributed age wise, 
  
    
Age (in years) Number Percent 
0-10  4 4.5 
11-20 15 17.2 
21-30 10 11.4 
31-40 20 22.9 
41-50 8 9.1 
51-60 22 25.2 
61-70 8 9.1 
 
 
 
 
As would be expected the majority of the lesions were seen in the parotid glands – 
57 cases in total and submandibular glands were affected in 22 patients and the rest 
8 cases were of minor salivary gland lesions. When extrapolated into percentages 
this comes to be 65.51% parotid, 25.28% submandibular and 9.19% minor gland 
lesions. The sublingual and minor salivary glands are included in the same group.  
There was no separate distinctions among this minor gland group regarding their 
anatomical site. As is well known, the parotid gland lesions account for the 
maximum number of lesions followed by a considerable number of submandibular 
lesions. There were two cases of salivary gland tumours in cases clinically 
  
diagnosed as carcinoma cheek as these lesions arose from glands located in the 
mucosal aspect of the cheek. The final histopathology report was considered the 
definitive inclusion criteria. 
 Number Percent 
Parotid 57 65.51 
Submandibular 22 25.28% 
Minor 8 9.19% 
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No specific risk factors were identifiable and associations with smoking and 
tobacco use or past history of inflammatory disorders of these glands were not 
quantifiable or significant or both. There was no history of any previous irradiation 
in any of these patients. 
 
Pathologically these lesions were grouped into three broad categories of benign, 
malignant and non-neoplastic, the distribution of which was: 
 
Malignant  28.73% 
symptomatology
Three categories of lesions
  
Benign  34.48% 
Non-neoplastic 36.78% 
Individually the non-neoplastic lesions outnumber as the most frequently operated 
lesions but put together, benign and malignant neoplasms top the list. This sheds 
some light on the role of surgery in non-neoplastic lesions of the salivary glands.  
 Parotid:  57 cases 
    Benign  27 47.36% 
    Malignant  16 28.07% 
    Non-neoplastic 14 24.56% 
 Submandibular: 26 cases 
    Benign  5 23.8% 
    Malignant  4 19% 
    Non-neoplastic 12 57.1% 
 
 
 Minor/sublingual: 8 cases 
    Benign  1 12.5% 
    Malignant  4 50% 
      Non-neoplastic 3 37.5% 
 Parotid Submandibular Minor 
Benign 27 5 1 
  
Malignant 16 5 4 
Non-neoplastic 14 12 3 
 
And the specific pathological types among benign, malignant and     non-
neoplastic lesions according to their frequency –  
 Benign: 30 cases 
   Pleomorphic adenoma  24 
   Warthin’s tumour   2 
   Hamartoma    2 
   Monomorphic adenoma  1 
   Basal cell adenoma  1 
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As can be seen pleomorphic adenoma accounts for about 80% of all benign lesions 
of salivary glands and most of them indisputably occur in the parotid gland. 
 Malignant: 25 cases 
   Mucoepidermoid carcinoma 18 
 
    Low grade  11 
    Intermediate  1 
    High grade  6 
Malignant  
lesions 
Gland-wise 
distribution 
  
   Squamous cell carcinoma 3 
   Adenoid cystic carcinoma 2 
   Acinic cell carcinoma  1 
   Basal cell adenoma-M  1 
     
      
The predominance of mucoepidermoid carcinoma is no surprise though – but the 
occurrence of  squamous cell carcinoma and basal cell adenoma with 
transformation into malignancy are slightly in discordance with various other 
studies in literature. The grading of mucoepidermoid carcinoma helps to ascertain 
adjuvant radiotherapy and also gives valuable prognostic information. One of these 
patients in our study was pre operatively diagnosed as pleomorphic adenoma while 
the HPE report was that of mucoepidermoid carcinoma(high grade) and was then 
registered for radiotherapy, and the same patient developed sialocele as a post 
operative complication. 
 
 
The non-neoplastic swellings were 32 in number which on HPE : 
   Non specific inflammation  17 
   Chronic sialadenitis   12 
   Granulomatous    2 
   Cyst      1 
  
 
Most of these non-specific inflammations showed congestion and other features of 
inflammation with varying amounts of destruction of glandular architecture and 
were found unrelated to calculous diseases. The second in the list, of chronic 
sialadenitis included sialoliths also and these lesions were found predominantly in 
submandibular salivary gland. Of the two cases of granulomatous lesions one was 
suggestive of tuberculosis, and the patient was registered for anti-tuberculous 
therapy, but unfortunately could not be followed up. And the cystic lesion was a 
simple cyst with salivary glandular epithelial lining. 
 
The intraoperative issues were usually the careful identification and preservation of 
facial nerve and its branches. There was one case in which the main trunk of the 
facial nerve had to be sacrificed due to tumour infiltration though the patient did 
not have any clinically demonstrable nerve deficits preoperatively. There were no 
radical parotidectomies  done in the study period and those patients with facial 
nerve involvement were not operated in our institution during the study period – 
often due to the unwillingness of these patients when explained that the recovery 
chances of the neurological deficit were not high. And those patients who had post- 
operative facial nerve weakness, no obvious clues were identified intra-operatively. 
There were 7 such patients in our study out of which 4 improved with conservative 
treatment, and the other three had to be taught the necessary protective measures.5 
of these 7 patients were cases of malignant lesions and 1 benign and 1 
  
inflammatory lesion. And the recovered 4 cases were again 2 malignant, 1 benign 
and 1 inflammatory lesion. No reparative surgery was undertaken for any of these 
patients during the study period. 
 Benign Malignant Non-neoplastic 
Facial N palsy 1 5 1 
Resolved spon. 1 2 1 
 
 
The   role of  FNAC was also analyzed and it was found that about 20 cases 
(22.98%) proved to be different from the final tissue diagnosis. The false negative 
rate was higher than false-positive rate  in case of neoplasms. The commonest 
report on FNAC was pleomorphic adenoma and 10 of these cases turned out in the 
end to be different lesions. The sensitivity and specificity of this modality of 
investigation was computed and is as shown in the graphic representation. 
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Of the 87 cases of  FNAC reports, about 20 cases proved different from the final 
histopathological report. There were 4 false positive cases, 11 false negative cases. 
True positives were about 40 and true negatives 32 in our study. Taking these 
values and computing sensitivity and specificity, our study shows FNAC to be 78% 
sensitive and 88% specific. 
 
 
 
 
 
 
 
 
   Sialogram showing left parotitis 
 
     
Investigations like sialogram, ultrasonogram and CT scan were done in a few select 
cases as and when appropriate. Though these investigations proved to be more 
  
informative they cannot be indicated in all cases considering the cost-benefit ratio, 
hence these modalities of investigations were not routinely done in all patients. 
 
 
 
 
 
 
 
 
 
CT scan showing Left Parotid swelling 
Ultrasonogram of  salivary gland swelling 
  
 
 
Complications which occurred in the post-operative period were documented and 
analyzed. The list included facial nerve weakness, facial nerve palsy, flap necrosis, 
CT scan parotid 
  
wound infection, salivary fistula, sialocele and recurrence. Dysgeusia and dryness 
of mouth was reported by some patients but these symptoms spontaneously  
 
resolved and were not serious enough to be 
considered.
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The complications met with other than facial palsy were that of flap necrosis which 
occurred in 12 of our patients- 4 each in the three pathological categories-
accounting for about 13.9%. The next in the list was wound infection which was 
seen in 25 patients ranging from seropurulent discharge to wound gaping, this was 
seen more with non-neoplastic lesions than neoplastic lesions-in total of about 
20.8% of all the cases. Facial nerve weakness which resolved spontaneously and/or 
with steroids was observed in 7 cases – 6 of them being malignant lesions. This 
was numerically only 8.04%, and the average duration for this recovery was about 
16days. Rare complications like sialocele was seen in one patient, recurrence 
noticed in few cases but the primary surgery in these patients had been done earlier 
than the study period. Frey’s syndrome was not encountered with in any of these 
patients. 
  
 
All of these patients were discharged within two weeks when the minor 
complications if any were taken care of. They were asked to attend the review opd 
the following week when the biopsy report was ready and subsequent 
categorizations done accordingly. Those patients who required adjuvant therapy 
were then referred to radiotherapy department and followed up from there. Those 
who needed supportive treatment till complete remission of their otherwise 
innocuous symptoms were asked to attend the review opd weekly from then. Most 
of these patients were regular in their follow up and were able to give valuable 
information on their improvement or newer complaints, if any. 
   
However, this study and the analysis has its own limitations in that no radical surgery was 
done in the study cohort, no cases of facial nerve palsy were operated upon and neither was 
any neck dissection done. No cases of lesions of  deep lobe of parotid  were operated upon. 
Also the patients did not adhere to the follow-up protocol which made it difficult in few cases 
to document the results. 
 
 
 
 
 
Conclusions  
  
The analysis of our study cohort leaves us with the following 
inferences: 
¾ There is a great deal of surgical work to be done and is being 
satisfactorily done on salivary gland swellings in our institution. 
¾ The overall outcome remains considerably good both for the 
patient and the operative surgeon. 
¾ The role of surgery in non-neoplastic swellings is well made out 
and brought to light in this study. 
¾ The gland affected more is the parotid gland and the most 
common lesion is pleomorphic adenoma. 
¾ There is no sexual predominance in these lesions and the age 
incidence is higher in middle aged adults. 
¾ FNAC still proves to be complementary and the choicest modality 
with a sensitivity of 78% and specificity of 88% 
¾ The rate of complications are within acceptable limits and the 
patients are not disabled in the long-term analysis 
¾ The knowledge on radical surgeries and facial nerve repair is 
lacking in this study period and needs to be performed more in the 
near future 
¾ The numerical results of the various parameters analyzed prove to 
be in concurrence with  medical literature and other studies 
  
In short, this study brings it to the forefront that salivary gland 
surgery-a demanding and craftful field considered  as rarely 
performed- is in truth not so rare. The number and variety of cases in 
this particular surgical pathology is considerable and the results are 
laudable, the only hitch being the reluctance to perform radical 
surgery especially due to the limitations of investigating modalities. 
This study is not a path-breaking one but is a useful signpost for the 
future advancements in salivary gland surgery in our institution. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
clinical pictures of salivary gland swellings 
  
 
 
 
 
 
 
 
 
 
 
operative and post operative pictures 
  
MASTER CHART 
S.NO NAME AGE/SEX I.P.NO.. SYMP 
GL
AN
D 
V
II 
N 
FNAC SURGERY HPE COMP ADJ 
1 SANTHANAM  57/M     
PS 
838160 S M - I E I - - 
2 VEERAMMAL 35/F      
S2 
839131 S P - P SP P WI - 
3 KALIYAPERUMAL 57/M    S4 837272 S/P P - MEC TCP MEC-L FN + 
4 AYYASAMY 47/M   S2 840223 S P - P SP P - - 
5 CHELLATHURAI 50/M   S6 840363 S/P P + MEC TCP MEC-H FW + 
6 AMSAVALLI 35/F     S5 839728 S/P,D S - CSA E CSA NW - 
7 KOTTU 60/F     S3 840950 S P - W SP W - - 
8 RAJESWARI 40/F      
S1 
842992 S P - P SP P FN - 
9 SARATHA 60/F    S1 844696 S P - P SP P - - 
10 MALAIAMMAL 60/F     S6 846763 S S - P E P WI - 
11 AMSU 15/F     S2 846686 O P - CSA SP CSA WI - 
12 SAMIAPPAN 42/M    PS 868191 S/P,F P - I SP I FN - 
13 VERAN 30/M   PS 869214 S/P P - CSA SP CSA FW - 
14 RAMAYEE 40/F      
S3 
870556 S/P P - BCA SP BCA WI - 
15 PATTAMMAL 70/F     S5 870015 S,O P - MEC TCP MEC-H WI + 
16 ALLAPITCHAI 60/M    S1 872054 S/P S - CSA E SCC WI + 
17 SIVARAMAN 42/M    S6 874356 S P - P SP P FN - 
18 MARIMUTHU 70/F      
S2 
875561 S/P P - M SP M - - 
19 LOGAMBAL 70/F      
S4 
876011 S P - P SP P WI,FP - 
20 KITTURAR 57/M  S4 876681 S P - I SP I WI - 
21 BHUVANESHWARI 24/F  S6 876064 S P - P SP P - - 
22 CHANDRASEKARAN 23/M  S1 876790 S P - P SP MEC-L FN + 
23 VADIVEL 60/M  S4 878477 S/P S - CSA E CSA WI - 
24 VAHITHA BEGUM 32/F  S2 878244 S P - P SP MEC-L FW - 
25 THANGAVEL 60/M  S4 878978 S/P P - MEC TCP MEC-H WI + 
26 JEYAKUMARI 33/F  S2 879989 S/P P - P SP I WI - 
27 PARTHIBAN 35/M  S3 879693 S,LN P - P SP P WI - 
28 DHANASEKAR 38/M  PS 879844 S M - SCC WE SCC - + 
29 KALIYAMOORTHY 19/M  S3 880063 S/P S - I E G-TB WI + 
30 RAMKUMARI 62/F  S1 880592 S P - P SP P - - 
31 AARTHY 18/F  ENT 11286 S P - P SP P WI - 
32 NIRMALA 30/F  S2 883329 S/P S - CSA E CSA WI - 
33 SAROJINI 23/F  S6 884329 S P - P SP ACC - - 
34 KALAIVANAN 17/M  S5 885071 S,O S - CSA E CSL - - 
35 MANIKANDAN 15/M  S1 885844 S/P P - MEC TCP MEC-L WI,FP + 
36 GUNASUNDARI 40/F  ENT 110841 S,R P - P TCP P - - 
37 RAJENDRAN 42/M  S1 886318 S/P P - I SP C FN - 
38 SATHYA 12/F  P 180667 S M - I E MEC-L FW + 
39 BHAKYAVATHY 8/F  P 183652 S/P S - CSA E G WI - 
40 SELVA ANAND 28/M  S5 891600 S P - P SP P - - 
41 VELMURUGAN 35/M  S6 901280 S/P P - P SP MEC-L FW + 
42 SARATHKUMAR 3 ½ /M P 176294 DI P - I SP G WI - 
43 THANGARASU 60/M  S2 901361 S/P P - P SP P - - 
44 SAVARIRAJAN 33/M  S4 901993 S M - I E I - - 
45 NALLAMMAL 60/F   S5 902866 S/P P - I SP I - - 
46 MUTHUKUMAR 55/M   S1 939104 S,R P - MEC TCP MEC-I WI,FP + 
47 SUNDARAMBAL 40/F   S1 903096 S,R P - MEC TCP MEC-L FW + 
48 MURUGARAJAN 62/M   S4 904591 S S - I E I - - 
49 DURAIRAJ 31/M  S5  906103 S/P P - P SP I - - 
50 SHANKAR 5/M  P 118874 DI P - I SP I - - 
51 DHIVYA 12/F    S4 9067568 S S - P E P - - 
  
52 LAKSHMANAN 28/M  S3 926062 S/P P - MEC TCP MEC-L - - 
53 RAMAIYAN 44/M  S2 927011 S/P,O P - I SP I WI - 
54 CHANDRA 40/F   S2 928193 O M - ADC E ADC FW - 
55 KALIYAPERUMAL 55/M  S3 927301 S/P,O S - CSA E CSA FP - 
56 ELANCHIYAM 20/M   S6 928704 S P - P SP P - - 
57 RANJITHAM 29/F   S3 929464 S  P - P SP W WI - 
58 MALAIYAMMAL 66/F    S3 929804 S S - P E P - - 
59 RAMACHANDRAN 34/M  S3 931223 S P - P SP P - - 
60  JENNIFER 19/F   S2 932323 S,LN S - MEC E MEC-L - + 
61 KANNU 60/F   
ENT 
07988 O M - I E ADC - - 
62 SAMBANDHAM 57/M  S3 934579 S P - P SP P - - 
63 PUSHPAVALLI 37/F   S1 933883 S/P P - P SP I FN - 
64 SARAVANAN 18/M   S4 932999 S,LN S - I E I,H - - 
65 ANJALAI 60/F   S5 941574 S P - P SP P - - 
66 SARAVANAN 36/M    S3 943199 S P - P SP P - - 
67 AROKIASAMY 35/M   S5 942605 S/P S - CSA E CSA WI - 
68 SHANKAR 36/M    S1 944224 S/P P - MEC TCP BCA-M FN - 
69 RAMAIYAN 54/M    S5 947929 S/P,LN S - MEC E SCC WI,FP + 
70 SATHYA 20/F   
ENT 
32589 S/P S - CSA E CSA FN - 
71 DEVASAGAYAM 65/M   S1 954118 S/P P - P SP MEC-H - + 
72 RAMANATHAN 20/M  
ENT 
39638 S P - P SP P - - 
73 SARAVANAN 20/M   S4 938475 S/P P - I SP I - - 
74 CHANDRA 65/F  ENT 0309607 S P - P SP I WI - 
75 JEYALAKSHMI 48/F   S4 938977 S P - I SP C - - 
76 MUTHUKUMAR 55/M  PS 908311 S/P P - P SP MEC-I FN + 
77 MARIYAMMAL 40/F   S3 913018 S/P,O S - I E I - - 
78 MANICKAM 55/M  S5 917304 S/P S - MEC E MEC-L - + 
79 MARUTHAMBAL 63/F   S5 917312 S/P P - I SP P - - 
80 MALAIYAPPAN 63/M   S2 919581 S/P,LN S - CSA E CSA - - 
81 ANITHA 4/F      P 48284 S P - H SP H - - 
82 ANJALAI 33/F    S4 920404 S P - P SP P - - 
83 BALAMURUGAN 41/F    S3 920673 DI,O S - I E I - - 
84 SAKTHIVEL 12/M   P 49444 S P - P SP MEC-L FP + 
85 SABAPATHY 60/M    S3 927341 S S - MEC WE SCC WI + 
86 RANI 20/F    S3 928436 S P - P SP P FN - 
87 MALATHY 27/F      
S6 
928464 S,R M - P E P FN - 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
ABBREVIATIONS: 
 
 
 SYMPTOMS: 
  S  -  SWELLING 
  S/P  -  SWELLING WITH ASSOCIATED PAIN 
  O  -  OTHERS 
  DI  -  DISCHARGE 
 
 
 GLAND: 
  P  -  PAROTID 
  S  -  SUB MANDIBULAR 
  SL  -  SUB LINGUAL 
  M  -  MINOR SALIVARY GLANDS 
 
 
 
 FNAC   /   HPE: 
  P  -  PLEOMORPHIC ADENOMA 
  MEC  -  MUCO EPIDERMOID CARCINOMA(L- LOW,    
     I- INTERMEDIATE,  H- HIGH) 
  M  -  MONOMORPHIC ADENOMA 
  W  -  WARTHIN’S TUMOUR 
  ACC  -  ACINIC CELL CARCINOMA 
  ADC  -  ADENOID CYSTIC CARCINOMA 
  SCC  -  SQUAMOUS CELL CARCINOMA 
  BCA  -  BASAL CELL ADENOMA 
BCA-M                   - BASAL CELL ADENOMA WITH  MALIGNANT  
TRANSFORMATION 
H                             - HAMARTOMA 
CSA                        - CHRONIC SIALADENITIS 
G                             - GRANULOMATOUS 
C                             - CYST 
I                              - INFLAMMATORY 
 
 
 SURGERY: 
 
  E  -  EXCISION 
  WE  -  WIDE EXCISION 
  SP  -  SUPERFICIAL PAROTIDECTOMY 
  TCP  -  TOTAL CONSERVATIVE PAROTIDECTOMY 
 
 
 COMPLICATIONS: 
 
  FN  -  FLAP NECROSIS 
  WI  -  WOUND INFECTION 
  FW  -  FACIAL NERVE WEAKNESS 
  FP  -  FACIAL NERVE PALSY    
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    PROFORMA 
 
 
NAME:    AGE:     SEX: 
ADDRESS:    IP NO..: 
 
 
OCCUPATION: 
 
COMPLAINTS 
  SWELLING: 
 
   SITE: 
   DURATION: 
   RATE OF GROWTH: 
   ANY DISCHARGE: 
   IF YES, NATURE: 
   SUDEN CHANGE IN SIZE: 
  PAIN: 
   OVER THE SWELLING: 
   REFERRED PAIN TO EAR: 
   PAIN DURING MASTICATION: 
 
  ANY INCREASED SALIVATION 
  LOSS OF APPETITE/WEIGHT 
  NERVE INVOLVEMENT 
 
 
  PUS DISCHARGE-FROM SITES OF DUCTAL ORIFICES 
  BLOOD STAINED SALIVA 
  H/O SMOKING  
  ALCOHOL 
  TOBACCO CHEWING 
  H/O IRRADIATION 
  ANY FAMILY HISTORY 
 
 
 
 
CLINICAL EXAMINATION 
 
SWELLING 
  
  SITE   LIFTING OF EARLOBULE  SIZE 
 SURFACE  SHAPE           DISCHARGE
 MOBILITY      SKINCHANGES  WARMTH 
  TENDERNESS 
 PLANE OF THE SWELLING 
BIDIGITAL PALPATION 
SWELLING IN THE FLOOR OF MOUTH, ORAL CAVITY 
NERVE INVOLVEMENT 
CERVICAL LYMPHADENOPATHY 
 
 
 
INVESTIGATIONS 
  FNAC 
  CT SCAN 
  USG 
  SIALOGRAM 
  OTHERS FOR ASSESSMENT PURPOSE 
 
TREATMENT 
 
  SURGERY    -  SP,TCP,E,WE 
  RT 
  ATT 
 
 
POST OPERATIVE PERIOD 
  FLAP NECROSIS 
  WOUND INFECTION 
  FACIAL NERVE WEAKNESS 
  FACIAL NERVE PALSY 
  SIALOCELE 
  SALIVARY FISTULA 
 
RECURRENCE 
 
    
 
 
